ArticleOncology letters2024

Fisetin enhances cisplatin sensitivity in renal cell carcinoma via the CDK6/PI3K/Akt/mTOR signaling pathway.

Tingting Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.